L'hyperuricemie dans l'hypertension artérielte: quelle implication? [Hyperuricemia in hypertension: any clinical implication?]

Details

Ressource 1Download: RMS_L'hyperuricemie dans l'hypertension arterielle-quelle implication.pdf (208.53 [Ko])
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_009947C73008
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
L'hyperuricemie dans l'hypertension artérielte: quelle implication? [Hyperuricemia in hypertension: any clinical implication?]
Journal
Revue medicale suisse
Author(s)
Deléaval P., Burnier M.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
14/09/2005
Peer-reviewed
Oui
Volume
1
Number
32
Pages
2072-2074,2077-2079
Language
french
Notes
Publication types: English Abstract ; Journal Article ; Review
Publication Status: ppublish
Abstract
Twenty-five percent of untreated hypertensive patients are hyperuricemic. The causal role of uric acid in the pathogenesis of hypertension has not been clearly demonstrated in humans. An elevated serum uric acid appears to be predictive of the development of hypertension. Serum uric acid has also been considered as a cardiovascular risk factor but this issue is controversial. A high serum uric acid is associated with an increased cardiovascular morbidity and mortality in men. Thus, hyperuricemia in hypertensive patients should be considered as a sign of increased risk leading to a more intensive management of all other risk factors. When managing hypertensive patients with hyperuricemia, physicians should know the impact of antihypertensive drugs on serum uric acid to prevent a further increase in uric acid and the development of gout.
Keywords
Antihypertensive Agents/therapeutic use, Humans, Hypertension/complications, Hypertension/drug therapy, Hyperuricemia/complications, Hyperuricemia/drug therapy, Risk Factors
Pubmed
Create date
25/01/2008 13:55
Last modification date
20/07/2024 7:08
Usage data